NCT02862275 2025-10-23Atezolizumab in Treating Patients With Cancer Following Adoptive Cell TransferNational Cancer Institute (NCI)Phase 1 Active not recruiting40 enrolled
NCT01902173 2025-01-14Uprosertib, Dabrafenib, and Trametinib in Treating Patients With Stage IIIC-IV CancerNational Cancer Institute (NCI)Phase 1/2 Completed27 enrolled 16 charts